Coronary artery disease as the cause of incident heart failure in the population.
about
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trialDebate: Statins should be used in patients with heart failureHeart failure in the Middle EastThe physiology of cardiovascular disease and innovative liposomal platforms for therapyHeart failure and socioeconomic status: accumulating evidence of inequalityWill changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UKHigh-sensitivity cardiac troponin T: risk stratification tool in patients with symptoms of chest discomfortThe heart failure epidemic: a UK perspectiveCardiac mechanics and ventricular twist by three-dimensional strain analysis in relation to B-type natriuretic peptide as a clinical prognosticator for heart failure patients.Management of chronic heart failure.The heart failure epidemic.Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) StudyInfluence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.Myocardial contrast echocardiography for the detection of coronary artery disease in patients with global hypokinesis admitted for first-onset acute heart failure: pilot studyIncidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom.PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.Preventing clinical heart failure: the rationale and scientific evidence.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with theDiagnostic and prognostic value of absence of coronary artery calcification in patients with stable chest symptoms.The causes, consequences, and treatment of left or right heart failureBeneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction.Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of CopenhagenEthnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community: the Harrow heart failure watchAssociation of SNP Rs9943582 in APLNR with Left Ventricle Systolic Dysfunction in Patients with Coronary Artery Disease in a Chinese Han GeneID PopulationInfluence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failureThe epidemiological enigma of heart failure with preserved systolic function.Gender and heart failure: a population perspectiveEchocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.Coronary artery disease and outcome in acute congestive heart failureA history of arterial hypertension does not affect mortality in patients hospitalised with congestive heart failureExtracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.Clinical epidemiology of heart failure.Hypertension--still an important cause of heart failure?Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan AfricaDiagnosis and assessment of the heart failure patient: the cornerstone of effective management.Social isolation, vital exhaustion, and incident heart failure: findings from the Atherosclerosis Risk in Communities Study.Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities studyFractalkine neutralization improves cardiac function after myocardial infarction.Worldwide risk factors for heart failure: a systematic review and pooled analysis.Primary and secondary prevention of heart failure with statins.
P2860
Q24793341-46CAE130-B90E-4515-ADBD-3655042A66ADQ24799320-0F0BD690-8A9D-42E8-95C9-9E4BA477BEE8Q26865181-893D367C-91E0-461C-B6CA-11C4FE9E4647Q27002949-D993798E-46ED-47E9-AB35-13F6D5F524FAQ27012972-316E5C2D-2BBD-4345-9BE8-D61918804123Q28168828-FD98C2D2-0314-4EFF-95D3-E4F1A979F57BQ28730261-ED0DC894-557F-4051-BCFF-2534595552FBQ30235952-D87C1737-5C56-4104-B587-D33CBC0D5370Q30421429-AE04DDE6-8313-4EDA-8CEB-E0101E5EDFC7Q33811699-4192EA99-C7FC-48C6-BD40-FA01D5B6B1BCQ33858952-7D5927A0-0901-4CBA-B394-E7D0AAFBE258Q34056118-48FF994E-DF9A-4A3B-8DCE-1F44C1156CFCQ34248663-0E8898FC-E82E-40A8-B546-5BCF08B4AA7EQ34317034-5DB0CA66-4354-4EE1-A6AF-FCAE847B912EQ34395504-0B875E35-5508-48C7-8509-2351DE20DD8AQ34412608-BA112A6E-C63E-4439-9B96-2AC5B883C830Q34816982-60282BAB-AF49-45DC-8FD5-919EBD6CE007Q34830023-676B6FE5-DF58-4B3F-BCF1-8C08FA8BECA8Q34918355-5F4D9242-1A62-4F82-AFB8-6911A38A2849Q34987168-FD44A469-9A9A-4C95-8D50-FA9732356704Q35048419-219B481E-E1A5-42FF-8F62-DC2205FC23B7Q35581829-0C939734-91B3-4492-95BD-66C12A74DC56Q35584198-D58D4072-41CE-4589-8032-BDEA8EECD206Q35625343-426F3233-BACA-4EB2-8C41-7A46DCB17FCDQ35660105-7D87CED2-9E30-497B-ADCB-5EB3DEEAD6C7Q35676021-3510C640-F860-46DE-BCE1-3574B0145F9DQ35771154-61F98DE5-404B-4B2A-A60E-8FB4BABE13D9Q35771726-DC90FD3E-678C-463B-B7A1-7136A0240005Q35771747-2235D8E1-6312-4045-9C34-FCD52EFE2AFCQ35771978-A9714DA5-3D9D-4D9A-83E3-7A00557A1B52Q35907034-B7C9C494-7863-41FE-94B6-B9E7ED84B60EQ35954269-4FE95766-06D8-41A4-B9D4-294262418CEEQ36014335-B1368CF1-4CB0-4A6C-8C07-25DAAC3BF14BQ36025679-63CFA8BF-EBBD-4A74-8AC1-7D475FA072E5Q36046578-F4377784-966B-4911-AB7C-C38DAE49B1EAQ36050637-3C03678F-FAE9-4D6A-B53A-56296585C884Q36057771-6FD65CAB-5604-406D-8BEC-B122EC29F1BEQ36390463-AD2E3628-EFB1-4C02-9069-C309ACE8E472Q36675427-4C595EED-ECEA-4A29-A8CA-E9F96AE4B8D9Q36686069-05F178B2-E7F9-49C1-8E57-8D8053895E75
P2860
Coronary artery disease as the cause of incident heart failure in the population.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Coronary artery disease as the cause of incident heart failure in the population.
@ast
Coronary artery disease as the cause of incident heart failure in the population.
@en
type
label
Coronary artery disease as the cause of incident heart failure in the population.
@ast
Coronary artery disease as the cause of incident heart failure in the population.
@en
prefLabel
Coronary artery disease as the cause of incident heart failure in the population.
@ast
Coronary artery disease as the cause of incident heart failure in the population.
@en
P2093
P356
P1476
Coronary artery disease as the cause of incident heart failure in the population.
@en
P2093
Poole-Wilson PA
Underwood SR
P304
P356
10.1053/EUHJ.2000.2289
P577
2001-02-01T00:00:00Z